期刊文献+

耐亚胺培南铜绿假单胞菌医院感染现状及监测 被引量:32

Nosocomial Infection and Antimicrobial Resistance Surveillance among Imipenem-resistant Clinical Isolates of Pseudomonas aeruginosa
下载PDF
导出
摘要 目的探讨耐亚胺培南铜绿假单胞菌医院感染现状及其对13种常用抗菌药物的耐药性,指导临床合理选用抗菌药物。方法用常规方法对289株铜绿假单胞菌临床株进行鉴定,并采用Kirty-Bauer法选用13种抗菌药物进行药物敏感试验。结果106株耐亚胺培南铜绿假单胞菌的分离率为36.7%,主要来源于痰标本,占78.3%;其在临床病区分布中居前3位者依次为呼吸内科、神经外科、老年病科;106株铜绿假单胞菌对氯霉素、复方新诺明等8种抗菌药物均表现出>50%的耐药率。结论耐亚胺培南铜绿假单胞菌医院感染严重,对抗菌药物呈多重耐药,治疗此类细菌感染宜参考细菌药敏结果合理选用抗菌药物。 OBJECTIVE To investigate the nosoeomial status and drug resistance spectrum of imipenem-resistant Pseudomonas aeruginosa. METHODS VITEK32 was used for the identification of 289 P. aeruginosa clinical isolates and the resistance of 13 kinds antibiotics was determined by Kirby-Bauer method. RESULTS Totally 106 strains of imipenem-resistant P. aeruginosa were mainly isolated from departments of respiratory diseases, neurosurgery and geriatrics, most of them were from sputum (78.3%). Result of susceptibility test showed that P. aeruginosa was highly resistant to ehloramphenieol, SMZ, etc. The trend of multidrug resistance of imipenemresistant P. aeruginosa was increasing. CONCLUSIONS The status of nosoeomial infection caused by imipenemresistant P. aeruginosa is very serious, and these strains show multidrug resistance. To control this kind of infection, we must choose antibiotic rationally according the result of susceptibility test.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2005年第9期1058-1060,共3页 Chinese Journal of Nosocomiology
关键词 亚胺培南 铜绿假单胞菌 医院感染 耐药性 Imipenem Pseudomonasaeruginosa Nosocomial infection Antimicrobial resistance
  • 相关文献

参考文献5

二级参考文献40

  • 1Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections[J]. Science, 1999, 284(5418): 1318-1322.
  • 2Kumon H, Ono N, Iida M, et al. Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm[J]. Antimicrob Agents Chemother, 1995, 39(5): 1038-1044.
  • 3Kumon H, Tomochika K, Matunaga T, et al. A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides[J]. Microbiol Immunol, 1994, 38(8): 615-619.
  • 4National Committee for Clinical Laboratory Standards.Performance Standards for Antimicrobial Susceptibility Testing;Ninth Informational Supplement,NCCLS documents M100-S9[S].Pennsylvania:NCCLS,1999.1-103.
  • 5Levy S.Multidrug resistance-a sign of the times[J].N Engl J Med,1998,338:1376-1378.
  • 6Witte W.Antibiotic resistance in Gram-positive bacteria:epidemiological aspects[J].J Antimicrob Chemother,1999,44Topic A:1-9.
  • 7Andrews J,Ashby J,Jevons G,et al.Antimicrobial resistance in Gram-positive pathogens isolated in the UK between October 1996 and January 1997[J].J Antimicrob Chemother,1999,43:689-698.
  • 8Schmitz FJ,Verhoef J,Fluif AC,et al.Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY Surveillance Propramme[J].J Antimicrob Chemother,1999,41:783-792.
  • 9Costerton JW. Bacterial biofilms in nature and diseases [J]. Ann Rev Microbiol,1987, 41: 435-464.
  • 10Anwar H, Strap JL, Costerton JW. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy [J]. Antimicrob Agent Chemother,1992, 36(7): 1347-1351.

共引文献190

同被引文献202

引证文献32

二级引证文献284

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部